Anagrelide Hcl
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00261 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 62 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | reactive thrombocytosis | KG + DL |
| 2 | inverse Klippel-Trenaunay syndrome | KG + DL |
| 3 | dermatofibrosarcoma protuberans | KG + DL |
| 4 | rheumatoid arthritis | KG + DL |
| 5 | rheumatoid factor-positive polyarticular juvenile idiopathic arthritis | KG + DL |
| 6 | juvenile idiopathic arthritis | KG + DL |
| 7 | osteoarthritis | KG + DL |
| 8 | pseudoachondroplasia | KG + DL |
| 9 | rheumatoid nodulosis | KG + DL |
| 10 | juvenile chronic polyarthritis | KG + DL |
| 11 | osteoarthritis susceptibility | KG + DL |
| 12 | brachydactyly-syndactyly syndrome | KG + DL |
| 13 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 14 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 15 | juvenile arthritis due to defect in LACC1 | KG + DL |
| 16 | myosclerosis | KG + DL |
| 17 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 18 | brachyolmia | KG + DL |
| 19 | extracutaneous mastocytoma | KG + DL |
| 20 | mantle cell lymphoma | KG + DL |
| 21 | WHIM syndrome | KG + DL |
| 22 | great vessel cancer | KG + DL |
| 23 | arthropathy | KG + DL |
| 24 | aggressive systemic mastocytosis | KG + DL |
| 25 | conventional fibrosarcoma | KG + DL |
| 26 | fibroblastic neoplasm | KG + DL |
| 27 | kidney fibrosarcoma | KG + DL |
| 28 | heart fibrosarcoma | KG + DL |
| 29 | low grade fibromyxoid sarcoma | KG + DL |
| 30 | gout | KG + DL |
| 31 | leukoplakia | KG + DL |
| 32 | amyotrophic lateral sclerosis | KG + DL |
| 33 | bilateral parasagittal parieto-occipital polymicrogyria | KG + DL |
| 34 | malignant peritoneal mesothelioma | KG + DL |
| 35 | amyotrophic lateral sclerosis, susceptibility to | KG + DL |
| 36 | Smouldering systemic mastocytosis | KG + DL |
| 37 | mastocytosis | KG + DL |
| 38 | systemic mastocytosis | KG + DL |
| 39 | indolent systemic mastocytosis | KG + DL |
| 40 | pleural mesothelioma | KG + DL |
| 41 | amyotrohpic lateral sclerosis type 22 | KG + DL |
| 42 | combined immunodeficiency due to moesin deficiency | KG + DL |
| 43 | Mills syndrome | KG + DL |
| 44 | pleural adenomatoid tumor | KG + DL |
| 45 | psoriasis-related juvenile idiopathic arthritis | KG + DL |
| 46 | malaria | KG + DL |
| 47 | axial spondylometaphyseal dysplasia | KG + DL |
| 48 | autosomal recessive familial Mediterranean fever | KG + DL |
| 49 | heme oxygenase 1 deficiency | KG + DL |
| 50 | lymphoadenopathic mastocytosis with eosinophilia | KG + DL |
(Showing top 50 of 62 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.